Sensitive PCR-based Monitoring and Early Detection of Relapsed JAK2 V617F Myelofibrosis Following Transplantation

British Journal of Haematology - United Kingdom
doi 10.1111/bjh.15059
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Results of a Phase 2 Study of Pacritinib (SB1518), a JAK2/JAK2(V617F) Inhibitor, in Patients With Myelofibrosis

Blood
BiochemistryImmunologyCell BiologyHematology
2015English

Janus Kinase V617F Mutation Detection in Patients With Myelofibrosis

Balkan Journal of Medical Genetics
Genetics
2019English

Phenotypic Variations and New Mutations in JAK2 V617F–negative Polycythemia Vera, Erythrocytosis, and Idiopathic Myelofibrosis

Experimental Hematology
Cancer ResearchGeneticsHematologyMolecular BiologyCell Biology
2007English

JAK2-V617F-mediated Signalling Is Dependent on Lipid Rafts and Statins Inhibit JAK2-V617F-dependent Cell Growth

British Journal of Haematology
Hematology
2012English

Screening of JAK2 V617F Mutation in Multiple Myeloma

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2006English

Kronik Miyeloproliferatif Hastalık Olgularında JAK2 V617F Mutasyon Sıklığı

Harran Üniversitesi Tıp Fakültesi Dergisi
2019English

JAK2 V617F Mutation in Adult T Cell Leukemia-Lymphoma

Indian Journal of Hematology and Blood Transfusion
Hematology
2015English

Early Allogeneic Transplantation for Refractory or Relapsed Acute Leukaemia Following Remission Induction With FLAG

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
1999English

Evaluation on Thrombotic Events Frequency in JAK2 V617F Positive Patients

Journal of Hematology & Thromboembolic Diseases
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy